vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$117.7M vs $75.5M），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $14.4M）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
PBYI vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.6倍
$75.5M
自由现金流更多
RHLD
多$174.8M
$14.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $117.7M |
| 净利润 | — | $-1.7M |
| 毛利率 | 69.3% | 55.7% |
| 营业利润率 | 22.7% | 30.2% |
| 净利率 | — | -1.5% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRHLD
| Q4 25 | $75.5M | $117.7M | ||
| Q3 25 | $54.5M | $120.9M | ||
| Q2 25 | $52.4M | $119.6M | ||
| Q1 25 | $46.0M | $103.9M | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $80.5M | — | ||
| Q2 24 | $47.1M | — | ||
| Q1 24 | $43.8M | — |
净利润PBYIRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $8.8M | $-231.0K | ||
| Q2 25 | $5.9M | $-611.0K | ||
| Q1 25 | $3.0M | $-3.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-4.8M | — |
毛利率PBYIRHLD
| Q4 25 | 69.3% | 55.7% | ||
| Q3 25 | 77.7% | 59.0% | ||
| Q2 25 | 76.5% | 57.5% | ||
| Q1 25 | 77.1% | 52.5% | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIRHLD
| Q4 25 | 22.7% | 30.2% | ||
| Q3 25 | 17.6% | 34.3% | ||
| Q2 25 | 12.7% | 34.0% | ||
| Q1 25 | 8.7% | 24.7% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率PBYIRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | 16.2% | -0.2% | ||
| Q2 25 | 11.2% | -0.5% | ||
| Q1 25 | 6.5% | -3.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | -9.6% | — | ||
| Q1 24 | -11.0% | — |
每股收益（稀释后）PBYIRHLD
| Q4 25 | $0.26 | $-0.20 | ||
| Q3 25 | $0.17 | $-0.03 | ||
| Q2 25 | $0.12 | $-0.07 | ||
| Q1 25 | $0.06 | $-0.39 | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $205.5M |
| 总债务越低越好 | $22.7M | $169.8M |
| 股东权益账面价值 | $130.3M | $6.5M |
| 总资产 | $216.3M | $333.4M |
| 负债/权益比越低杠杆越低 | 0.17× | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资PBYIRHLD
| Q4 25 | $97.5M | $205.5M | ||
| Q3 25 | $94.4M | $148.0M | ||
| Q2 25 | $96.0M | $99.9M | ||
| Q1 25 | $93.2M | $71.0M | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYIRHLD
| Q4 25 | $22.7M | $169.8M | ||
| Q3 25 | $34.0M | $173.4M | ||
| Q2 25 | $45.3M | $177.1M | ||
| Q1 25 | $56.7M | $180.7M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIRHLD
| Q4 25 | $130.3M | $6.5M | ||
| Q3 25 | $115.3M | $10.8M | ||
| Q2 25 | $104.7M | $9.6M | ||
| Q1 25 | $97.1M | $8.9M | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | — | ||
| Q2 24 | $48.5M | — | ||
| Q1 24 | $51.0M | — |
总资产PBYIRHLD
| Q4 25 | $216.3M | $333.4M | ||
| Q3 25 | $202.9M | $293.2M | ||
| Q2 25 | $194.9M | $253.3M | ||
| Q1 25 | $196.2M | $214.3M | ||
| Q4 24 | $213.3M | — | ||
| Q3 24 | $220.7M | — | ||
| Q2 24 | $205.0M | — | ||
| Q1 24 | $214.1M | — |
负债/权益比PBYIRHLD
| Q4 25 | 0.17× | 26.03× | ||
| Q3 25 | 0.30× | 16.01× | ||
| Q2 25 | 0.43× | 18.42× | ||
| Q1 25 | 0.58× | 20.38× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $189.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 160.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $313.2M |
8季度趋势，按日历期对齐
经营现金流PBYIRHLD
| Q4 25 | $14.4M | $196.1M | ||
| Q3 25 | $9.7M | $59.6M | ||
| Q2 25 | $14.1M | $48.9M | ||
| Q1 25 | $3.6M | $18.4M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $11.2M | — |
自由现金流PBYIRHLD
| Q4 25 | $14.4M | $189.2M | ||
| Q3 25 | $9.7M | $58.6M | ||
| Q2 25 | $14.1M | $47.5M | ||
| Q1 25 | $3.6M | $17.8M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIRHLD
| Q4 25 | 19.1% | 160.8% | ||
| Q3 25 | 17.7% | 48.5% | ||
| Q2 25 | 26.8% | 39.7% | ||
| Q1 25 | 7.7% | 17.1% | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIRHLD
| Q4 25 | 0.0% | 5.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIRHLD
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
